BMS Archive

Plant · Scientific monograph

Moringa oleifera

Moringa

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Metabolic research, Nutrition research

Research overview

Historical use

Moringa leaves, pods and seeds are used as foods and in traditional practices, but their composition and exposures differ; clinical findings must remain part-specific [1,2].

Modern research context

A meta-analysis of randomized studies found no consistent cardiometabolic benefit and rated the evidence very low certainty [1]. A short postpartum study of dried leaf powder found no statistically significant difference in its primary milk-volume outcome. It does not establish benefit or infant safety [2].

Adverse effects

The included studies vary in part and preparation and do not establish long-term safety. The postpartum trial does not establish infant safety from its primary outcome [1,2].

Contraindications

Do not recommend moringa to increase milk volume or infer safety in lactation from the trial. Avoid generalizing between leaf, seed and pod products [1,2].

Clinical and phytochemical data

Used part

Parts studied vary; the milk-volume trial used leaf capsules, whereas cardiometabolic trials used varied products [1,2].

Primary active compounds

    Mechanism of action

    The RCTs assess clinical outcomes and do not establish a general human mechanism for the plant [1]. The cited human studies do not characterize an active compound or establish constituent-specific activity.

    Pharmacokinetics

    Absorption

    Human PK data were not established in the cited meta-analysis or RCT [1,2].

    Distribution

    Not characterized.

    Metabolism

    Not characterized.

    Excretion

    Not characterized.

    Safety and interactions

    Drug interactions

    No comprehensive species- and preparation-specific interaction profile established by these sources.

    Toxicity

    Very-low-certainty efficacy evidence does not establish overall safety; long-term toxicity remains insufficiently characterized [1,2].

    Special precautions

    Pregnancy

    Medicinal-dose pregnancy safety is not established across parts and preparations.

    Lactation

    The leaf-capsule RCT does not establish a milk-volume benefit; safety in lactation and for the infant is not established [2].

    Hepatic impairment

    No impairment-specific evidence identified.

    Renal impairment

    No impairment-specific evidence identified.

    Sources and references

    1. [1] Diana Crișan et al. Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. Nutrients. 2025;17(22):3501. PMID: 41305552. DOI: 10.3390/nu17223501.
    2. [2] Siraphat Fungtammasan, Vorapong Phupong. The effect of Moringa oleifera capsule in increasing breast milk volume in early postpartum patients: A double-blind, randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2022;16:100171. PMID: 36440058. DOI: 10.1016/j.eurox.2022.100171.

    Additional source links

    Continue browsing